These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 23549431

  • 1. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
    Salzer J, Nyström M, Hallmans G, Stenlund H, Wadell G, Sundström P.
    Mult Scler; 2013 Oct; 19(12):1587-91. PubMed ID: 23549431
    [Abstract] [Full Text] [Related]

  • 2. Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
    Ruprecht K, Wunderlich B, Gieß R, Meyer P, Loebel M, Lenz K, Hofmann J, Rosche B, Wengert O, Paul F, Reimer U, Scheibenbogen C.
    J Neuroimmunol; 2014 Jul 15; 272(1-2):56-61. PubMed ID: 24798244
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up.
    DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A.
    Arch Neurol; 2006 Jun 15; 63(6):839-44. PubMed ID: 16606758
    [Abstract] [Full Text] [Related]

  • 4. Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis.
    Cortese M, Leng Y, Bjornevik K, Mitchell M, Healy BC, Mina MJ, Mancuso JD, Niebuhr DW, Munger KL, Elledge SJ, Ascherio A.
    JAMA Neurol; 2024 May 01; 81(5):515-524. PubMed ID: 38497939
    [Abstract] [Full Text] [Related]

  • 5. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
    Strautins K, Tschochner M, James I, Choo L, Dunn DS, Pedrini M, Kermode A, Carroll W, Nolan D.
    Mult Scler; 2014 Mar 01; 20(3):286-94. PubMed ID: 23886832
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernán MA, Olek MJ, Hankinson SE, Hunter DJ.
    JAMA; 2001 Dec 26; 286(24):3083-8. PubMed ID: 11754673
    [Abstract] [Full Text] [Related]

  • 7. Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.
    Huang J, Tengvall K, Lima IB, Hedström AK, Butt J, Brenner N, Gyllenberg A, Stridh P, Khademi M, Ernberg I, Al Nimer F, Manouchehrinia A, Hillert J, Alfredsson L, Andersen O, Sundström P, Waterboer T, Olsson T, Kockum I.
    Brain; 2024 Oct 03; 147(10):3573-3582. PubMed ID: 38630618
    [Abstract] [Full Text] [Related]

  • 8. Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
    Wergeland S, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Kvistad SS, Holmøy T, Riise T, Torkildsen Ø.
    Eur J Neurol; 2016 Jun 03; 23(6):1064-70. PubMed ID: 26998820
    [Abstract] [Full Text] [Related]

  • 9. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
    Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A.
    JAMA; 2005 May 25; 293(20):2496-500. PubMed ID: 15914750
    [Abstract] [Full Text] [Related]

  • 10. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J, Khaleeli Z, Schmierer K, Miller DH, Giovannoni G.
    Neurology; 2009 Jul 07; 73(1):32-8. PubMed ID: 19458321
    [Abstract] [Full Text] [Related]

  • 11. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
    Munger KL, Levin LI, O'Reilly EJ, Falk KI, Ascherio A.
    Mult Scler; 2011 Oct 07; 17(10):1185-93. PubMed ID: 21685232
    [Abstract] [Full Text] [Related]

  • 12. The interaction between smoking and Epstein-Barr virus as multiple sclerosis risk factors may depend on age.
    Salzer J, Stenlund H, Sundström P.
    Mult Scler; 2014 May 07; 20(6):747-50. PubMed ID: 24107308
    [Abstract] [Full Text] [Related]

  • 13. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.
    Jafari N, van Nierop GP, Verjans GM, Osterhaus AD, Middeldorp JM, Hintzen RQ.
    J Clin Virol; 2010 Sep 07; 49(1):26-31. PubMed ID: 20638898
    [Abstract] [Full Text] [Related]

  • 14. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
    Schlemm L, Giess RM, Rasche L, Pfuhl C, Wakonig K, Behrens JR, Scheibenbogen C, Bellmann-Strobl J, Paul F, Reimer U, Ruprecht K.
    J Neuroimmunol; 2016 Aug 15; 297():56-62. PubMed ID: 27397076
    [Abstract] [Full Text] [Related]

  • 15. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.
    Yamazaki M, Kitamura R, Kusano S, Eda H, Sato S, Okawa-Takatsuji M, Aotsuka S, Yanagi K.
    Clin Exp Immunol; 2005 Mar 15; 139(3):558-68. PubMed ID: 15730403
    [Abstract] [Full Text] [Related]

  • 16. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.
    Najafipoor A, Roghanian R, Zarkesh-Esfahani SH, Bouzari M, Etemadifar M.
    Cell Immunol; 2015 Mar 15; 294(1):9-12. PubMed ID: 25666504
    [Abstract] [Full Text] [Related]

  • 17. Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis.
    Wagner HJ, Hennig H, Jabs WJ, Siekhaus A, Wessel K, Wandinger KP.
    Viral Immunol; 2000 Mar 15; 13(4):497-502. PubMed ID: 11192296
    [Abstract] [Full Text] [Related]

  • 18. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study.
    Sundström P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nyström L, Dillner J, Forsgren L.
    Neurology; 2004 Jun 22; 62(12):2277-82. PubMed ID: 15210894
    [Abstract] [Full Text] [Related]

  • 19. Multiple sclerosis and Epstein-Barr virus.
    Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A.
    JAMA; 2003 Mar 26; 289(12):1533-6. PubMed ID: 12672770
    [Abstract] [Full Text] [Related]

  • 20. Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.
    Rolf L, Muris AH, Mathias A, Du Pasquier R, Koneczny I, Disanto G, Kuhle J, Ramagopalan S, Damoiseaux J, Smolders J, Hupperts R.
    Mult Scler; 2018 Sep 26; 24(10):1280-1287. PubMed ID: 28731372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.